GW Pharmaceuticals CEO Justin Gover tells Jim Cramer the company plans to launch the first CBD-based epilepsy drug in Europe ‘over the next year or two.’
2 responses to “GW Pharma CEO explains company's plan for CBD-based epilepsy drug”
What about the UK! Its a UK company selling it and we can't get our hands on this "medicine"🙄😔
What about the UK!
Its a UK company selling it and we can't get our hands on this "medicine"🙄😔
I tried calling.